101
|
Viral and non-viral gene delivery and its role in pluripotent stem cell engineering. DRUG DISCOVERY TODAY. TECHNOLOGIES 2013; 5:e105-48. [PMID: 24125542 DOI: 10.1016/j.ddtec.2008.10.002] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
102
|
|
103
|
Han L, Ravoori M, Wu G, Sakai R, Yan S, Singh S, Xu K, Roth JA, Ji L, Kundra V. Somatostatin Receptor Type 2–Based Reporter Expression after Plasmid-Based in Vivo Gene Delivery to Non–Small Cell Lung Cancer. Mol Imaging 2013; 12:7290.2013.00060. [DOI: 10.2310/7290.2013.00060] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/30/2023] Open
Affiliation(s)
- Lin Han
- From the Departments of Experimental Diagnostic Imaging, Thoracic and Cardiovascular Surgery, and Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Murali Ravoori
- From the Departments of Experimental Diagnostic Imaging, Thoracic and Cardiovascular Surgery, and Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Guanglin Wu
- From the Departments of Experimental Diagnostic Imaging, Thoracic and Cardiovascular Surgery, and Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Ryo Sakai
- From the Departments of Experimental Diagnostic Imaging, Thoracic and Cardiovascular Surgery, and Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Shaoyu Yan
- From the Departments of Experimental Diagnostic Imaging, Thoracic and Cardiovascular Surgery, and Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Sheela Singh
- From the Departments of Experimental Diagnostic Imaging, Thoracic and Cardiovascular Surgery, and Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Kai Xu
- From the Departments of Experimental Diagnostic Imaging, Thoracic and Cardiovascular Surgery, and Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Jack A. Roth
- From the Departments of Experimental Diagnostic Imaging, Thoracic and Cardiovascular Surgery, and Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Lin Ji
- From the Departments of Experimental Diagnostic Imaging, Thoracic and Cardiovascular Surgery, and Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Vikas Kundra
- From the Departments of Experimental Diagnostic Imaging, Thoracic and Cardiovascular Surgery, and Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
| |
Collapse
|
104
|
Han L, Ravoori M, Wu G, Sakai R, Yan S, Singh S, Xu K, Roth JA, Ji L, Kundra V. Somatostatin receptor type 2-based reporter expression after plasmid-based in vivo gene delivery to non-small cell lung cancer. Mol Imaging 2013; 12:1-10. [PMID: 23962694 PMCID: PMC4103180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/02/2023] Open
Abstract
Plasmids tend to have much lower expression than viruses. Gene expression after systemic administration of plasmid vectors has not been assessed using somatostatin receptor type 2 (SSTR2)-based reporters. The purpose of this work was to identify gene expression in non-small cell lung cancer (NSCLC) after systemic liposomal nanoparticle delivery of plasmid containing SSTR2-based reporter gene. In vitro, Western blotting was performed after transient transfection with the plasmid cytomegalovirus (CMV)-SSTR2, CMV-TUSC2-IRES-SSTR2, or CMV-TUSC2. SSTR2 is the reporter gene, and TUSC2 is a therapeutic gene. Mice with A549 NSCLC lung tumors were injected intravenously with CMV-SSTR2, CMV-TUSC2-IRES-SSTR2, or CMV-TUSC2 plasmids in DOTAP:cholesterol-liposomal nanoparticles. Two days later, mice were injected intravenously with 111In-octreotide. The next day, biodistribution was performed. The experiment was repeated including single-photon emission computed tomography/computed tomography (SPECT/CT). Immunohistochemistry was performed. In vitro, SSTR2 expression was similar in cells transfected with CMV-SSTR2 or CMV-TUSC2-IRES-SSTR2. TUSC2 expression was similar in cells transfected with CMV-TUSC2 or CMV-TUSC2-SSTR2. Biodistribution demonstrated significantly greater 111In-octreotide uptake in tumors from mice injected with CMV-TUSC2-IRES-SSTR2 or CMV-SSTR2 than the control plasmid, CMV-TUSC2 (p < .05). Gamma-camera and SPECT/CT imaging illustrated SSTR2 expression in tumors in mice injected with CMV-TUSC2-IRES-SSTR2 or CMV-SSTR2 versus background with control plasmid. Immunohistochemistry corresponded with imaging. SSTR2-based reporter imaging can visualize gene expression in lung tumors after systemic liposomal nanoparticle delivery of plasmid containing SSTR2-based reporter gene or SSTR2 linked to a second therapeutic gene, such as TUSC2.
Collapse
MESH Headings
- Animals
- Carcinoma, Non-Small-Cell Lung/genetics
- Carcinoma, Non-Small-Cell Lung/metabolism
- Carcinoma, Non-Small-Cell Lung/therapy
- Cell Line, Tumor
- Cytomegalovirus/genetics
- Female
- Genes, Reporter
- Genetic Therapy
- Genetic Vectors
- Heterografts
- Humans
- Indium Radioisotopes
- Liposomes
- Lung Neoplasms/genetics
- Lung Neoplasms/metabolism
- Lung Neoplasms/therapy
- Mice
- Mice, Nude
- Neoplasm Transplantation
- Octreotide/analogs & derivatives
- Plasmids
- Radiopharmaceuticals
- Receptors, Somatostatin/genetics
- Receptors, Somatostatin/metabolism
- Tomography, Emission-Computed, Single-Photon/methods
- Tumor Cells, Cultured
- Tumor Suppressor Proteins/genetics
- Tumor Suppressor Proteins/metabolism
Collapse
Affiliation(s)
- Lin Han
- Department of Experimental Diagnostic Imaging
| | | | - Guanglin Wu
- Department of Thoracic and Cardiovascular Surgery
| | - Ryo Sakai
- Department of Thoracic and Cardiovascular Surgery
| | - Shaoyu Yan
- Department of Thoracic and Cardiovascular Surgery
| | | | - Kai Xu
- Department of Thoracic and Cardiovascular Surgery
| | - Jack A. Roth
- Department of Thoracic and Cardiovascular Surgery
| | - Lin Ji
- Department of Thoracic and Cardiovascular Surgery
| | - Vikas Kundra
- Department of Experimental Diagnostic Imaging
- Department of Diagnostic Radiology
| |
Collapse
|
105
|
Kerkar SP. "Model t" cells: a time-tested vehicle for gene therapy. Front Immunol 2013; 4:304. [PMID: 24098300 PMCID: PMC3784795 DOI: 10.3389/fimmu.2013.00304] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2013] [Accepted: 09/12/2013] [Indexed: 01/01/2023] Open
Abstract
T lymphocytes first carried foreign genes safely into humans over two decades ago. Since these pioneering studies, scientific techniques to better understand the genomic landscape of cells has directly led to a more sophisticated appreciation of the diversity, functional complexity, and therapeutic potential of T cells. Through the use of mouse models, we now know the function of the many genes that are critical for T cells to recognize foreign, mutated, or self-antigens and the factors responsible for the lineage diversification of T cells that lead to inhibitory or stimulatory immune responses. This knowledge combined with well-established modalities to introduce genes into T cells allows for the design of effector and memory CD8 and CD4 T lymphocytes specific for viral, fungal, bacterial, parasitic, and tumor-antigens and to design regulatory lymphocytes specific for the self-antigens responsible for autoimmune and inflammatory diseases. Here, I review strategies for designing the ideal T cell by introducing genes controlling (1) the secretion of cytokines/chemokines and their receptors, (2) T-cell receptor specificity, (3) chimeric-antigen receptors that enable for the recognition of surface antigens in an MHC-independent fashion, (4) co-stimulatory/inhibitory surface molecules, and (5) disease defining single-gene factors.
Collapse
Affiliation(s)
- Sid P Kerkar
- Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD , USA
| |
Collapse
|
106
|
Zhou T, Llizo A, Wang C, Xu G, Yang Y. Nanostructure-induced DNA condensation. NANOSCALE 2013; 5:8288-8306. [PMID: 23838744 DOI: 10.1039/c3nr01630g] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
The control of the DNA condensation process is essential for compaction of DNA in chromatin, as well as for biological applications such as nonviral gene therapy. This review endeavours to reflect the progress of investigations on DNA condensation effects of nanostructure-based condensing agents (such as nanoparticles, nanotubes, cationic polymer and peptide agents) observed by using atomic force microscopy (AFM) and other techniques. The environmental effects on structural characteristics of nanostructure-induced DNA condensates are also discussed.
Collapse
Affiliation(s)
- Ting Zhou
- National Center for Nanoscience and Technology (NCNST), Beijing 100190, PR China
| | | | | | | | | |
Collapse
|
107
|
Wang C, Ravi S, Garapati US, Das M, Howell M, MallelaMallela J, Alwarapan S, Mohapatra SS, Mohapatra S. Multifunctional Chitosan Magnetic-Graphene (CMG) Nanoparticles: a Theranostic Platform for Tumor-targeted Co-delivery of Drugs, Genes and MRI Contrast Agents. J Mater Chem B 2013; 1:4396-4405. [PMID: 24883188 PMCID: PMC4036826 DOI: 10.1039/c3tb20452a] [Citation(s) in RCA: 100] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Combing chemotherapy with gene therapy has been one of the most promising strategies for the treatment of cancer. The noninvasive MRI with superparamagnetic iron oxide (SPIO) as contrast agent is one of the most effecitve techniques for evaluating the antitumor therapy. However, to construct a single system that can deliver efficiently gene, drug and SPIO to the cancer site remains a challenge. Herein, we report a chitosan functionalized magnetic graphene nanoparticle (CMG) platform for simultaneous gene/drug and SPIO delivery to tumor. The phantom and ex vivo MRI images suggest CMG as a strong T2 contrast-enhancing agent. The CMGs are biocompatible as evaluated by the WST assay and predominantly accumulate in tumors as shown by biodistribution studies and MRI. The anticancer drug doxorubicin (DOX) loaded CMGs (DOX-CMGs) release DOX faster at pH 5.1 than at pH 7.4, and more effective (IC50 = 2 μM) in killing A549 lung cancer cells than free DOX (IC50 = 4 μM). CMGs efficiently deliver DNA into A549 lung cancer cells and C42b prostate cancer cells. In addition, i.v. administration of GFP-plasmid encapsulated within DOX-CMGs into tumor-bearing mice has showed both GFP expression and DOX accumulation at the tumor site at 24 and 48 hrs after administration. These results indicate CMGs provide a robust and safe theranostic platform, which integrates targeted delivery of both gene medicine and chemotherapeutic drug(s), and enhanced MR imaging of tumors. The integrated chemo- and gene- therapeutic and diagnostic design of CMG nanoparticles shows promise for simultaneous targeted imaging, drug delivery and real -time monitoring of therapeutic effect for cancer.
Collapse
Affiliation(s)
- Chunyan Wang
- Molecular Medicine Department, University of South Florida, 12901 Bruce B Downs Blvd,Tampa, FL, 33612,U.S.A
- USF Nanomedicine Research Center, University of South Florida, 12901 Bruce B Downs Blvd,Tampa, FL, 33612,U.S.A
| | - Sowndharya Ravi
- Molecular Medicine Department, University of South Florida, 12901 Bruce B Downs Blvd,Tampa, FL, 33612,U.S.A
| | - Ujjwala Sree Garapati
- Molecular Medicine Department, University of South Florida, 12901 Bruce B Downs Blvd,Tampa, FL, 33612,U.S.A
| | - Mahasweta Das
- USF Nanomedicine Research Center, University of South Florida, 12901 Bruce B Downs Blvd,Tampa, FL, 33612,U.S.A
- Division of Translational Medicine, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B Downs Blvd,Tampa, FL, 33612,U.S.A
| | - Mark Howell
- Molecular Medicine Department, University of South Florida, 12901 Bruce B Downs Blvd,Tampa, FL, 33612,U.S.A
- USF Nanomedicine Research Center, University of South Florida, 12901 Bruce B Downs Blvd,Tampa, FL, 33612,U.S.A
| | - Jaya MallelaMallela
- Molecular Medicine Department, University of South Florida, 12901 Bruce B Downs Blvd,Tampa, FL, 33612,U.S.A
- USF Nanomedicine Research Center, University of South Florida, 12901 Bruce B Downs Blvd,Tampa, FL, 33612,U.S.A
| | - Subbiah Alwarapan
- USF Nanomedicine Research Center, University of South Florida, 12901 Bruce B Downs Blvd,Tampa, FL, 33612,U.S.A
- Division of Translational Medicine, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B Downs Blvd,Tampa, FL, 33612,U.S.A
| | - Shyam S. Mohapatra
- USF Nanomedicine Research Center, University of South Florida, 12901 Bruce B Downs Blvd,Tampa, FL, 33612,U.S.A
- Division of Translational Medicine, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B Downs Blvd,Tampa, FL, 33612,U.S.A
| | - Subhra Mohapatra
- Molecular Medicine Department, University of South Florida, 12901 Bruce B Downs Blvd,Tampa, FL, 33612,U.S.A
- USF Nanomedicine Research Center, University of South Florida, 12901 Bruce B Downs Blvd,Tampa, FL, 33612,U.S.A
| |
Collapse
|
108
|
Synthesis and preliminary cellular evaluation of phosphonium chitosan derivatives as novel non-viral vector. Carbohydr Polym 2013; 97:676-83. [DOI: 10.1016/j.carbpol.2013.05.036] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2013] [Revised: 05/09/2013] [Accepted: 05/16/2013] [Indexed: 12/20/2022]
|
109
|
Transfection and intracellular trafficking properties of carbon dot-gold nanoparticle molecular assembly conjugated with PEI-pDNA. Biomaterials 2013; 34:7168-80. [DOI: 10.1016/j.biomaterials.2013.05.072] [Citation(s) in RCA: 134] [Impact Index Per Article: 12.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2013] [Accepted: 05/27/2013] [Indexed: 11/23/2022]
|
110
|
|
111
|
Kim YK, Cho CS, Cho MH, Jiang HL. Spermine-alt-poly(ethylene glycol) polyspermine as a safe and efficient aerosol gene carrier for lung cancer therapy. J Biomed Mater Res A 2013; 102:2230-7. [DOI: 10.1002/jbm.a.34905] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2013] [Revised: 07/23/2013] [Accepted: 07/30/2013] [Indexed: 01/06/2023]
Affiliation(s)
- You-Kyoung Kim
- State Key Laboratory of Natural Medicines; Department of Pharmaceutics; China Pharmaceutical University; Nanjing 210009 People's Republic of China
| | - Chong-Su Cho
- Research Institute for Agriculture and Life Sciences; Seoul National University; Seoul 151-921 Korea
| | - Myung-Haing Cho
- Laboratory of Toxicology; College of Veterinary Medicine; Seoul National University; Seoul 151-742 Korea
- Graduate School of Convergence Science and Technology; Seoul National University; Suwon 443-270 Korea
- Graduate Group of Tumor Biology; Seoul National University; Seoul 151-742 Korea
- Advanced Institute of Convergence Technology; Seoul National University; Suwon 443-270 Korea
| | - Hu-Lin Jiang
- State Key Laboratory of Natural Medicines; Department of Pharmaceutics; China Pharmaceutical University; Nanjing 210009 People's Republic of China
| |
Collapse
|
112
|
Togashi R, Harashima H, Kamiya H. Correlation between transgen expression and plasmid DNA loss in mouse liver. J Gene Med 2013; 15:242-8. [DOI: 10.1002/jgm.2716] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2013] [Revised: 06/10/2013] [Accepted: 06/10/2013] [Indexed: 11/08/2022] Open
Affiliation(s)
- Ryohei Togashi
- Faculty of Pharmaceutical Sciences; Hokkaido University; Sapporo; Japan
| | | | | |
Collapse
|
113
|
In vivo bioluminescence reporter gene imaging for the activation of neuronal differentiation induced by the neuronal activator neurogenin 1 (Ngn1) in neuronal precursor cells. Eur J Nucl Med Mol Imaging 2013; 40:1607-17. [PMID: 23754760 DOI: 10.1007/s00259-013-2457-0] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2013] [Accepted: 05/03/2013] [Indexed: 10/26/2022]
Abstract
PURPOSE Facilitation of the ability of neuronal lineages derived from transplanted stem cells to differentiate is essential to improve the low efficacy of neuronal differentiation in stem cell therapy in vivo. Neurogenin 1 (Ngn1), a basic helix-loop-helix factor, has been used as an activator of neuronal differentiation. In this study, we monitored the in vivo activation of neuronal differentiation by Ngn1 in neuronal precursor cells using neuron-specific promoter-based optical reporters. METHODS The NeuroD promoter coupled with the firefly luciferase reporter system (pNeuroD-Fluc) was used to monitor differentiation in F11 neuronal precursor cells. In vitro luciferase activity was measured and normalized by protein content. The in vivo-jetPEI(TM) system was used for in vivo transgene delivery. The IVIS 100 imaging system was used to monitor in vivo luciferase activity. RESULTS The Ngn1-induced neuronal differentiation of F11 cells generated neurite outgrowth within 2 days of Ngn1 induction. Immunofluorescence staining demonstrated that early and late neuronal marker expression (βIII-tubulin, NeuroD, MAP2, NF-M, and NeuN) was significantly increased at 3 days after treatment with Ngn1. When Ngn1 and the pNeuroD-Fluc vector were cotransfected into F11 cells, we observed an approximately 11-fold increase in the luciferase signal. An in vivo study showed that bioluminescence signals were gradually increased in Ngn1-treated F11 cells for up to 3 days. CONCLUSION In this study, we examined the in vivo tracking of neuronal differentiation induced by Ngn1 using an optical reporter system. This reporter system could be used effectively to monitor the activation efficiency of neuronal differentiation in grafted stem cells treated with Ngn1 for stem cell therapy.
Collapse
|
114
|
Cochran M, Wheatley MA. In vitro gene delivery with ultrasound-triggered polymer microbubbles. ULTRASOUND IN MEDICINE & BIOLOGY 2013; 39:1102-19. [PMID: 23562023 PMCID: PMC3683598 DOI: 10.1016/j.ultrasmedbio.2013.01.013] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/25/2012] [Revised: 12/16/2012] [Accepted: 01/22/2013] [Indexed: 05/05/2023]
Abstract
In the work described here, gene delivery using polymer microbubbles triggered by ultrasound in vitro was investigated. The effects of pressure amplitude (0-2 MPa), center frequency (1-5 MHz), pulse length (3-12,000 μs), pulse repetition frequency (5-20,000 Hz) and exposure time (0-30 s) on transfection efficiency and cell viability were examined. The effects of radiation force, calcium ion concentration and timing of treatments were also examined. Cells were successfully transfected with pressure amplitudes as low as 250 kPa. Transfection was most efficient at lower frequencies and longer pulse lengths, with a transfection efficiency of 24.2 ± 2.0% achieved using a center frequency of 1 MHz, pressure amplitude of 1 MPa, pulse length of 12,000 μs and pulse repetition frequency of 5 Hz. Gene delivery was also affected by the extracellular calcium ion concentration and the timing of treatments.
Collapse
Affiliation(s)
| | - Margaret A. Wheatley
- Corresponding author: Margaret A. Wheatley, Ph.D., School of Biomedical Engineering, Science and Health Systems, Drexel University, 3141 Chestnut Street, Philadelphia, PA 19104, Tel: (215) 895 2232, Fax: (215) 895 4983,
| |
Collapse
|
115
|
Caramelo-Nunes C, Almeida P, Marcos J, Tomaz C. Specific recognition of supercoiled plasmid DNA by affinity chromatography using the intercalator DAPP as ligand. J Chromatogr B Analyt Technol Biomed Life Sci 2013; 928:121-4. [DOI: 10.1016/j.jchromb.2013.04.001] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2012] [Revised: 03/08/2013] [Accepted: 04/01/2013] [Indexed: 12/29/2022]
|
116
|
MAR elements and transposons for improved transgene integration and expression. PLoS One 2013; 8:e62784. [PMID: 23646143 PMCID: PMC3640020 DOI: 10.1371/journal.pone.0062784] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2013] [Accepted: 03/24/2013] [Indexed: 01/01/2023] Open
Abstract
Reliable and long-term expression of transgenes remain significant challenges for gene therapy and biotechnology applications, especially when antibiotic selection procedures are not applicable. In this context, transposons represent attractive gene transfer vectors because of their ability to promote efficient genomic integration in a variety of mammalian cell types. However, expression from genome-integrating vectors may be inhibited by variable gene transcription and/or silencing events. In this study, we assessed whether inclusion of two epigenetic control elements, the human Matrix Attachment Region (MAR) 1–68 and X-29, in a piggyBac transposon vector, may lead to more reliable and efficient expression in CHO cells. We found that addition of the MAR 1–68 at the center of the transposon did not interfere with transposition frequency, and transgene expressing cells could be readily detected from the total cell population without antibiotic selection. Inclusion of the MAR led to higher transgene expression per integrated copy, and reliable expression could be obtained from as few as 2–4 genomic copies of the MAR-containing transposon vector. The MAR X-29-containing transposons was found to mediate elevated expression of therapeutic proteins in polyclonal or monoclonal CHO cell populations using a transposable vector devoid of selection gene. Overall, we conclude that MAR and transposable vectors can be used to improve transgene expression from few genomic transposition events, which may be useful when expression from a low number of integrated transgene copies must be obtained and/or when antibiotic selection cannot be applied.
Collapse
|
117
|
Gautam A, Chaudhary K, Kumar R, Sharma A, Kapoor P, Tyagi A, Raghava GPS. In silico approaches for designing highly effective cell penetrating peptides. J Transl Med 2013; 11:74. [PMID: 23517638 PMCID: PMC3615965 DOI: 10.1186/1479-5876-11-74] [Citation(s) in RCA: 206] [Impact Index Per Article: 18.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2012] [Accepted: 03/11/2013] [Indexed: 11/23/2022] Open
Abstract
Background Cell penetrating peptides have gained much recognition as a versatile transport vehicle for the intracellular delivery of wide range of cargoes (i.e. oligonucelotides, small molecules, proteins, etc.), that otherwise lack bioavailability, thus offering great potential as future therapeutics. Keeping in mind the therapeutic importance of these peptides, we have developed in silico methods for the prediction of cell penetrating peptides, which can be used for rapid screening of such peptides prior to their synthesis. Methods In the present study, support vector machine (SVM)-based models have been developed for predicting and designing highly effective cell penetrating peptides. Various features like amino acid composition, dipeptide composition, binary profile of patterns, and physicochemical properties have been used as input features. The main dataset used in this study consists of 708 peptides. In addition, we have identified various motifs in cell penetrating peptides, and used these motifs for developing a hybrid prediction model. Performance of our method was evaluated on an independent dataset and also compared with that of the existing methods. Results In cell penetrating peptides, certain residues (e.g. Arg, Lys, Pro, Trp, Leu, and Ala) are preferred at specific locations. Thus, it was possible to discriminate cell-penetrating peptides from non-cell penetrating peptides based on amino acid composition. All models were evaluated using five-fold cross-validation technique. We have achieved a maximum accuracy of 97.40% using the hybrid model that combines motif information and binary profile of the peptides. On independent dataset, we achieved maximum accuracy of 81.31% with MCC of 0.63. Conclusion The present study demonstrates that features like amino acid composition, binary profile of patterns and motifs, can be used to train an SVM classifier that can predict cell penetrating peptides with higher accuracy. The hybrid model described in this study achieved more accuracy than the previous methods and thus may complement the existing methods. Based on the above study, a user- friendly web server CellPPD has been developed to help the biologists, where a user can predict and design CPPs with much ease. CellPPD web server is freely accessible at http://crdd.osdd.net/raghava/cellppd/.
Collapse
Affiliation(s)
- Ankur Gautam
- Bioinformatics Centre, CSIR-Institute of Microbial Technology, Chandigarh 160036, India
| | | | | | | | | | | | | | | |
Collapse
|
118
|
Aravalli RN. Development of MicroRNA Therapeutics for Hepatocellular Carcinoma. Diagnostics (Basel) 2013; 3:170-91. [PMID: 26835673 PMCID: PMC4665582 DOI: 10.3390/diagnostics3010170] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2013] [Revised: 03/01/2013] [Accepted: 03/11/2013] [Indexed: 12/11/2022] Open
Abstract
Hepatocellular carcinoma (HCC) is the most common form of liver cancer and is the third leading cause of cancer-related deaths worldwide. Treatment options for HCC are very limited, as it is often diagnosed at a late stage. Recent studies have demonstrated that microRNAs (miRNAs), a class of non-coding RNAs, are aberrantly expressed in HCC. Some of these were shown to be functionally involved in carcinogenesis and tumor progression, suggesting that miRNAs can serve as novel molecular targets for HCC therapy. Several promising studies have recently demonstrated the therapeutic potential of miRNAs in animal models and in reducing the viral load in hepatitis C patients. In this review, these advances and strategies for modulating miRNAs for in vivo therapeutic delivery and replacement therapy are discussed.
Collapse
Affiliation(s)
- Rajagopal N Aravalli
- Department of Radiology, University of Minnesota Medical School, MMC 292 Mayo Memorial Building, 420 Delaware Street S.E., Minneapolis, MN 55455, USA.
| |
Collapse
|
119
|
Durigutto P, Macor P, Ziller F, De Maso L, Fischetti F, Marzari R, Sblattero D, Tedesco F. Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5. PLoS One 2013; 8:e58696. [PMID: 23505550 PMCID: PMC3591401 DOI: 10.1371/journal.pone.0058696] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2012] [Accepted: 02/05/2013] [Indexed: 01/25/2023] Open
Abstract
Treatment of patients suffering from chronic diseases such as rheumatoid arthritis with recombinant antibodies is time consuming and fairly expensive and can be associated with side effects due to generalized depletion of the target molecule. We have addressed these issues by developing an alternative approach consisting of the intraarticular injection of a DNA vector encoding for the anti-C5 neutralizing recombinant miniantibody MB12/22. This method allows local production of the antibody in sufficient amount to be effective in preventing joint inflammation in a rat model of antigen-induced arthritis. Injection of the DNA vector in a right knee of normal rats resulted in the production of the minibody detected in the synovial washes by western blot with a strong signal peaking at 3 days after administration. DNA encoding for the minibody was shown for 14 days in the synovial tissue and was undetectable in the controlateral knee and in other organs. The preventive effect of this approach was evaluated in rats receiving a single injection of the vector 3 days before the induction of antigen-induced arthritis and analyzed 3 days later. The treated rats exhibited a lower increase in swelling, associated with a lower number of PMN in the articular washes and reduced deposition of C9 in synovial tissue compared to control rats. These results suggest that treating the inflamed joints with a vector that induces a local production of a neutralizing anti-C5 antibody may represent a useful strategy to inhibit in situ complement activation and to treat patients with monoarthritis. Moreover, this approach may be adopted as a novel therapeutic strategy to prevent monoarthritis as an alternative to local treatment with antibodies commonly used in this form of arthritis, with the advantages of the lower cost and the longer persistence of antibody production.
Collapse
Affiliation(s)
- Paolo Durigutto
- Department of Life Sciences, University of Trieste, Trieste, Italy
| | - Paolo Macor
- Department of Life Sciences, University of Trieste, Trieste, Italy
- * E-mail:
| | - Federica Ziller
- Department of Life Sciences, University of Trieste, Trieste, Italy
| | - Luca De Maso
- Department of Life Sciences, University of Trieste, Trieste, Italy
| | - Fabio Fischetti
- Dipartimento Universitario Clinico di Scienze Mediche, Chirurgiche e della Salute, University of Trieste, Trieste, Italy
| | - Roberto Marzari
- Department of Life Sciences, University of Trieste, Trieste, Italy
| | - Daniele Sblattero
- Department of Medical Sciences and IRCAD, University of Eastern Piedmont, Novara, Italy
| | | |
Collapse
|
120
|
Shirmanova MV, Serebrovskaya EO, Lukyanov KA, Snopova LB, Sirotkina MA, Prodanetz NN, Bugrova ML, Minakova EA, Turchin IV, Kamensky VA, Lukyanov SA, Zagaynova EV. Phototoxic effects of fluorescent protein KillerRed on tumor cells in mice. JOURNAL OF BIOPHOTONICS 2013; 6:283-90. [PMID: 22696211 DOI: 10.1002/jbio.201200056] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/28/2012] [Revised: 05/12/2012] [Accepted: 05/21/2012] [Indexed: 06/01/2023]
Abstract
KillerRed is known to be a unique red fluorescent protein displaying strong phototoxic properties. Its effectiveness has been shown previously for killing bacterial and cancer cells in vitro. Here, we investigated the photototoxicity of the protein on tumor xenografts in mice. HeLa Kyoto cell line stably expressing KillerRed in mitochondria and in fusion with histone H2B was used. Irradiation of the tumors with 593 nm laser led to photobleaching of KillerRed indicating photosensitization reaction and caused significant destruction of the cells and activation of apoptosis. The portion of the dystrophically changed cells increased from 9.9% to 63.7%, and the cells with apoptosis hallmarks from 6.3% to 14%. The results of this study suggest KillerRed as a potential genetically encoded photosensitizer for photodynamic therapy of cancer.
Collapse
Affiliation(s)
- Marina V Shirmanova
- Nizhny Novgorod State Medical Academy, 603005 Minin Sq., 10/1, Nizhny Novgorod, Russia.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
121
|
Adamo A, Roushdy O, Dokov R, Sharei A, Jensen K. Microfluidic jet injection for delivering macromolecules into cells. JOURNAL OF MICROMECHANICS AND MICROENGINEERING : STRUCTURES, DEVICES, AND SYSTEMS 2013; 23:035026. [PMID: 23956498 PMCID: PMC3744198 DOI: 10.1088/0960-1317/23/3/035026] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
We present a microfluidic based injection system designed to achieve intracellular delivery of macromolecules by directing a picoliter-jet of a solution towards individual cells. After discussing the concept, we present design specification and criteria, elucidate performance and discuss results. The method has the potential to be quantitative and high throughput, overcoming limitations of current intracellular delivery protocols.
Collapse
Affiliation(s)
- A. Adamo
- Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - O. Roushdy
- Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - R. Dokov
- Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - A. Sharei
- Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - K.F. Jensen
- Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA
| |
Collapse
|
122
|
Allen MH, Day KN, Hemp ST, Long TE. Synthesis of Folic Acid-Containing Imidazolium Copolymers for Potential Gene Delivery Applications. MACROMOL CHEM PHYS 2013. [DOI: 10.1002/macp.201200613] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
123
|
Mornet E, Carmoy N, Lainé C, Lemiègre L, Le Gall T, Laurent I, Marianowski R, Férec C, Lehn P, Benvegnu T, Montier T. Folate-equipped nanolipoplexes mediated efficient gene transfer into human epithelial cells. Int J Mol Sci 2013; 14:1477-501. [PMID: 23344053 PMCID: PMC3565331 DOI: 10.3390/ijms14011477] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2012] [Revised: 12/31/2012] [Accepted: 01/06/2013] [Indexed: 11/16/2022] Open
Abstract
Since recombinant viral vectors have been associated with serious side effects, such as immunogenicity and oncogenicity, synthetic delivery systems represent a realistic alternative for achieving efficacy in gene therapy. A major challenge for non-viral nanocarriers is the optimization of transgene expression in the targeted cells. This goal can be achieved by fine-tuning the chemical carriers and the adding specific motifs to promote cellular penetration. Our study focuses on the development of novel folate-based complexes that contain varying quantities of folate motifs. After controlling for their physical properties, neutral folate-modified lipid formulations were compared in vitro to lipoplexes leading to comparable expression levels. In addition, no cytotoxicity was detected, unlike what was observed in the cationic controls. Mechanistically, the delivery of the transgene appeared to be, in part, due to endocytosis mediated by folate receptor targeting. This mechanism was further validated by the observation that adding free folate into the medium decreased luciferase expression by 50%. In vivo transfection with the folate-modified MM18 lipid, containing the highest amount of FA-PEG(570)-diether co-lipid (w:w; 90:10), at a neutral charge ratio, gave luciferase transgene expression. These studies indicate that modification of lipids with folate residues could enhance non-toxic, cell-specific gene delivery.
Collapse
Affiliation(s)
- Emmanuel Mornet
- INSERM U1078, IFR 148 ScInBIoS, Université de Bretagne Occidentale, 46 rue Félix Le Dantec, CS 51819, 29218 Brest Cedex 2, France; E-Mails: (E.M.); (N.C.); (T.L.G.); (C.F.); (P.L.)
- Ecole Nationale Supérieure de Chimie de Rennes, CNRS, UMR 6226, Avenue du Général Leclerc, CS 50837, 35708 Rennes Cedex 7, France; E-Mails: (C.L.); (L.L.); (I.L.); (T.B.)
- Service d’ORL et de chirurgie cervico-faciale, CHU de BREST hôpital Morvan, 2 avenue du maréchal Foch 29609 Brest, France; E-Mail:
| | - Nathalie Carmoy
- INSERM U1078, IFR 148 ScInBIoS, Université de Bretagne Occidentale, 46 rue Félix Le Dantec, CS 51819, 29218 Brest Cedex 2, France; E-Mails: (E.M.); (N.C.); (T.L.G.); (C.F.); (P.L.)
- IBiSA “SynNanoVect” platform, IFR 148 ScInBIoS, Faculté de Médecine, Université de Bretagne Occidentale, 22 avenue Camille Desmoulins, CS 93837–29238 Brest cedex, France
| | - Céline Lainé
- Ecole Nationale Supérieure de Chimie de Rennes, CNRS, UMR 6226, Avenue du Général Leclerc, CS 50837, 35708 Rennes Cedex 7, France; E-Mails: (C.L.); (L.L.); (I.L.); (T.B.)
| | - Loïc Lemiègre
- Ecole Nationale Supérieure de Chimie de Rennes, CNRS, UMR 6226, Avenue du Général Leclerc, CS 50837, 35708 Rennes Cedex 7, France; E-Mails: (C.L.); (L.L.); (I.L.); (T.B.)
- IBiSA “SynNanoVect” platform, IFR 148 ScInBIoS, Faculté de Médecine, Université de Bretagne Occidentale, 22 avenue Camille Desmoulins, CS 93837–29238 Brest cedex, France
| | - Tony Le Gall
- INSERM U1078, IFR 148 ScInBIoS, Université de Bretagne Occidentale, 46 rue Félix Le Dantec, CS 51819, 29218 Brest Cedex 2, France; E-Mails: (E.M.); (N.C.); (T.L.G.); (C.F.); (P.L.)
- IBiSA “SynNanoVect” platform, IFR 148 ScInBIoS, Faculté de Médecine, Université de Bretagne Occidentale, 22 avenue Camille Desmoulins, CS 93837–29238 Brest cedex, France
| | - Isabelle Laurent
- Ecole Nationale Supérieure de Chimie de Rennes, CNRS, UMR 6226, Avenue du Général Leclerc, CS 50837, 35708 Rennes Cedex 7, France; E-Mails: (C.L.); (L.L.); (I.L.); (T.B.)
| | - Remi Marianowski
- Service d’ORL et de chirurgie cervico-faciale, CHU de BREST hôpital Morvan, 2 avenue du maréchal Foch 29609 Brest, France; E-Mail:
| | - Claude Férec
- INSERM U1078, IFR 148 ScInBIoS, Université de Bretagne Occidentale, 46 rue Félix Le Dantec, CS 51819, 29218 Brest Cedex 2, France; E-Mails: (E.M.); (N.C.); (T.L.G.); (C.F.); (P.L.)
| | - Pierre Lehn
- INSERM U1078, IFR 148 ScInBIoS, Université de Bretagne Occidentale, 46 rue Félix Le Dantec, CS 51819, 29218 Brest Cedex 2, France; E-Mails: (E.M.); (N.C.); (T.L.G.); (C.F.); (P.L.)
| | - Thierry Benvegnu
- Ecole Nationale Supérieure de Chimie de Rennes, CNRS, UMR 6226, Avenue du Général Leclerc, CS 50837, 35708 Rennes Cedex 7, France; E-Mails: (C.L.); (L.L.); (I.L.); (T.B.)
- IBiSA “SynNanoVect” platform, IFR 148 ScInBIoS, Faculté de Médecine, Université de Bretagne Occidentale, 22 avenue Camille Desmoulins, CS 93837–29238 Brest cedex, France
| | - Tristan Montier
- INSERM U1078, IFR 148 ScInBIoS, Université de Bretagne Occidentale, 46 rue Félix Le Dantec, CS 51819, 29218 Brest Cedex 2, France; E-Mails: (E.M.); (N.C.); (T.L.G.); (C.F.); (P.L.)
- IBiSA “SynNanoVect” platform, IFR 148 ScInBIoS, Faculté de Médecine, Université de Bretagne Occidentale, 22 avenue Camille Desmoulins, CS 93837–29238 Brest cedex, France
- DUMG – Faculté de médecine, Université de Bretagne Occidentale, 22 avenue Camille Desmoulins, CS 93837–29238 Brest cedex, France
- CHRU de Brest, hôpital Morvan, 2 avenue du maréchal Foch 29609 Brest, France
- Author to whom correspondence should be addressed; E-Mail: ; Tel.: +33-2-98-01-80-80; Fax: +33-2-98-01-83-42
| |
Collapse
|
124
|
Arif M, Tripathi SK, Gupta KC, Kumar P. Self-assembled amphiphilic phosphopyridoxyl-polyethylenimine polymers exhibit high cell viability and gene transfection efficiency in vitro and in vivo. J Mater Chem B 2013; 1:4020-4031. [DOI: 10.1039/c3tb20516a] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
|
125
|
Wurster EC, Elbakry A, Göpferich A, Breunig M. Layer-by-layer assembled gold nanoparticles for the delivery of nucleic acids. METHODS IN MOLECULAR BIOLOGY (CLIFTON, N.J.) 2013; 948:171-82. [PMID: 23070770 DOI: 10.1007/978-1-62703-140-0_12] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
The delivery of nucleic acids to mammalian cells requires a potent particulate carrier system. The physicochemical properties of the used particles, such as size and surface charge, strongly influence the cellular uptake and thereby the extent of the subsequent biological effect. However the knowledge of this process is still fragmentary because heterogeneous particle collectives are applied. Therefore we present a strategy to synthesize carriers with a highly specific appearance on the basis of gold nanoparticles (AuNPs) and the Layer-by-Layer (LbL) technique. The LbL method is based on the alternate deposition of oppositely charged (bio-)polymers, in our case poly(ethylenimine) and nucleic acids. The size and surface charge of those particles can be easily modified and accordingly systematic studies on cellular uptake are accessible.
Collapse
Affiliation(s)
- Eva-Christina Wurster
- Department of Pharmaceutical Technology, University of Regensburg, Regensburg, Germany
| | | | | | | |
Collapse
|
126
|
Qin P, Xu L, Cai P, Hu Y, Yu ACH. Subcellular impact of sonoporation on plant cells: issues to be addressed in ultrasound-mediated gene transfer. ULTRASONICS SONOCHEMISTRY 2013; 20:247-53. [PMID: 22939002 DOI: 10.1016/j.ultsonch.2012.08.008] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/29/2012] [Revised: 07/31/2012] [Accepted: 08/01/2012] [Indexed: 06/01/2023]
Abstract
Sonoporation (membrane perforation via ultrasonic cavitation) is known to be realizable in plant cells on a reversible basis. However, cell viability may concomitantly be affected over the process, and limited knowledge is now available on how such cytotoxic impact comes about. This work has investigated how sonoporation may affect plant cells at a subcellular level and in turn activate programmed cell death (PCD). Tobacco BY-2 cells were used as the plant model, and sonoporation was applied through a microbubble-mediated approach with 100:1 cell-to-bubble ratio, free-field peak rarefaction pressure of either 0.4 or 0.9 MPa, and 1 MHz ultrasound frequency (administered in pulsed standing-wave mode at 10% duty cycle, 1 kHz pulse repetition frequency, and 1 min duration). Fluoroscopy results showed that sonoporated tobacco cells may undergo plasma membrane depolarization and reactive oxygen species elevation (two cellular disruption events closely connected to PCD). It was also found that the mitochondria of sonoporated tobacco cells may lose their outer membrane potential over time (observed using confocal microscopy) and consequently release stores of cytochrome-c proteins (determined by Western Blotting) into the cytoplasm to activate PCD. These findings provide insight into the underlying mechanisms responsible for sonoporation-induced cytotoxicity in plant cells. They should be taken into account when using this membrane perforation approach for gene transfection applications in plant biotechnology.
Collapse
Affiliation(s)
- Peng Qin
- Medical Engineering Program, The University of Hong Kong, Pokfulam, Hong Kong
| | | | | | | | | |
Collapse
|
127
|
Abstract
Appropriate gene delivery systems are essential for successful gene therapy in clinical medicine. Cationic lipid-mediated delivery is an alternative to viral vector-mediated gene delivery where transient gene expression is desirable. However, cationic lipid-mediated delivery of DNA to post-mitotic cells is often of low efficiency, due to the difficulty of DNA translocation to the nucleus. Rapid lipid-mediated delivery of RNA is preferable to nonviral DNA delivery in some clinical applications, because transit across the nuclear membrane is not necessary. Here we describe techniques for cationic lipid-mediated delivery of RNA encoding reporter genes in a variety of in vitro cell lines and in vivo. We describe optimized formulations and transfection procedures that we have previously assessed by flow cytometry. RNA transfection demonstrates increased efficiency relative to DNA transfection in nondividing cells. Delivery of mRNA results in onset of expression within 1 h after transfection and a peak in expression 5-7 h after transfection. These results are consistent with our in vivo delivery results, techniques for which are shown as well. Longer duration and the higher mean levels of expression per cell that are ultimately obtained following DNA delivery confirm a continuing role for DNA gene delivery in clinical applications that require long term transient gene expression. RNA delivery is suitable for short-term transient gene expression due to its rapid onset, short duration of expression, and greater efficiency, particularly in nondividing cells.
Collapse
Affiliation(s)
- James G Hecker
- Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, WA, USA.
| |
Collapse
|
128
|
Cho CS. Design and Development of Degradable Polyethylenimines for Delivery of DNA and Small Interfering RNA: An Updated Review. ACTA ACUST UNITED AC 2012. [DOI: 10.5402/2012/798247] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Polyethylenimine (PEI), considered as the most potent and promising alternative carrier to viral vectors, has been studied as the “state of the art” among various polymers for nonviral gene delivery applications for many years. Although PEI-based carrier minimizes the bottlenecks associated with viral vectors such as unwanted immunogenicity and production problems, the toxic side effects of PEI prevent its rapid advancements due to nondegradable nature. In this regard, various degradable cross-linking and/or grafting agents have been linked to synthesize degradable PEIs in order to minimize the toxicity and improve the efficacy of PEI-mediated gene carriers. This paper describes an update on various cross-linkers and grafting agents in the design and development of degradable PEI derivatives and their potential applications for effective delivery of DNA in vitro and in vivo. The molecular weight (MW) of PEI and the structural relationship to its cellular toxicity and transfection ability were also discussed. Finally, the potential applications of various degradable PEIs for small interfering RNA (siRNA)-mediated gene silencing were also covered.
Collapse
Affiliation(s)
- Chong-Su Cho
- Department of Agricultural Biotechnology and Research Institute for Agriculture and Life Sciences, Seoul National University, Seoul 151-921, Republic of Korea
| |
Collapse
|
129
|
Shah K, Connolly RJ, Chapman T, Jaroszeski MJ, Ugen KE. Electrogenetherapy of B16.F10 murine melanoma tumors with an interleukin-28 expressing DNA plasmid. Hum Vaccin Immunother 2012; 8:1722-8. [PMID: 23151446 DOI: 10.4161/hv.22560] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Augmented delivery of cytokine-expressing DNA plasmids to subcutaneous tumors has been demonstrated to result in a level of enhanced anti-tumor activity. One delivery enhancement method which has been evaluated is in vivo electroporation (EP), a contact-dependent delivery technique where electric pulses are hypothesized to augment the transfer of DNA into cells and tissues through the induction of temporary cell membrane pores. Previous work by members of our group, as well as others, has demonstrated the anti-tumor effects of DNA plasmids expressing the cytokines IL-12 and IL-15. In this report the potential anti-tumor activity of a relatively newly-described cytokine, IL-28, was measured when administered intratumorally as a DNA expression plasmid (designated pIL28) to established murine (B16.F10) melanoma tumors. The administration of the IL-28 expressing plasmid was performed through enhanced delivery methods. One method was EP and the other a non-contact dependent technique using a helium plasma stream. IL-28 is a member of the type III interferon family of cytokines that has been characterized as possessing potent anti-viral activity. This cytokine has been demonstrated to function as an adjuvant in small animal model vaccination protocols and stimulates CD8+ CTL responses. In addition, stimulation of anti-tumor activity has been demonstrated in several studies using IL-28. Based on these activities, it was hypothesized that this cytokine could, when delivered through a DNA expression plasmid, mediate anti-tumor activity. The results of this study indicated that enhanced delivery of pIL-28 resulted in attenuation of tumor growth, compared with non-enhanced delivery. Of note, this is the first proof-of-concept experiment, of our knowledge, documenting the ability of a non-contact dependent helium plasma-based delivery method to mediate the enhancement of an anti-tumor effect by a cytokine-expressing DNA plasmid. This suggests the use of the helium plasma delivery method as an alternative or adjunctive method to EP for the effective delivery of agents that possess potential anti-tumor activity.
Collapse
Affiliation(s)
- Kevin Shah
- Department of Molecular Medicine; Morsani College of Medicine; Tampa, FL USA
| | | | | | | | | |
Collapse
|
130
|
Liu Y, Bowen NJ, Matyunina L, McDonald J, Prausnitz MR. Gene transfection enhanced by ultrasound exposure combined with drug treatment guided by gene chip analysis. Int J Hyperthermia 2012; 28:349-61. [PMID: 22621736 DOI: 10.3109/02656736.2012.669513] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
PURPOSE Heterogeneous bioeffects have been reported in previous studies of ultrasound-mediated gene delivery. The goal of this study is to identify the differences between cells that take up plasmid DNA (pDNA) after sonication but are not transfected and cells that similarly take up pDNA but are transfected. We used these findings to select drugs that regulate intracellular processes expected to enhance gene transfection in combination with US. MATERIALS AND METHODS Gene expression among DU145 human prostate cancer cells after ultrasound-mediated transfection was analyzed using Affymetrix GeneChip Human Genome U133 Plus 2.0 Arrays. Drug treatments suggested by the microarray analysis were combined with US exposure to regulate the corresponding intracellular processes. Cell viability and transfection efficiency were determined by flow cytometry to analyze the effects of US combined with drug treatment. RESULTS Genes such as GADD45α (growth arrest and DNA-damage inducible, alpha) and Topoisomerase IIα were found to be associated with successful transfection. Drugs that regulate GADD45α and Topoisomerase IIα (e.g., ethyl methanesulfomate, amsacrine and chloroquine) were shown to increase ultrasound-mediated transfection efficiency by up to 2 fold. CONCLUSIONS Among cells with pDNA uptake after sonication, we found that genes are differentially expressed among transfected cells versus non-transfected cells. Regulation of the expression level of GADD45α and TOP2α and other intracellular processes can yield higher efficiency of ultrasound-mediated gene transfection. This suggests that a strategy to increase gene transfection efficiency involving the combination of sonication and regulation of intracellular processes using drugs could further enhance US-mediated gene transfection.
Collapse
Affiliation(s)
- Ying Liu
- School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA 30332-0100, USA
| | | | | | | | | |
Collapse
|
131
|
Schallon A, Synatschke CV, Jérôme V, Müller AHE, Freitag R. Nanoparticulate nonviral agent for the effective delivery of pDNA and siRNA to differentiated cells and primary human T lymphocytes. Biomacromolecules 2012; 13:3463-74. [PMID: 23020076 DOI: 10.1021/bm3012055] [Citation(s) in RCA: 63] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Delivery of polynucleotides such as plasmid DNA (pDNA) and siRNA to nondividing and primary cells by nonviral vectors presents a considerable challenge. In this contribution, we introduce a novel type of PDMAEMA-based star-shaped nanoparticles that (i) are efficient transfection agents in clinically relevant and difficult-to-transfect human cells (Jurkat T cells, primary T lymphocytes) and (ii) can efficiently deliver siRNA to human primary T lymphocytes resulting to more than 40% silencing of the targeted gene. Transfection efficiencies achieved by the new vectors in serum-free medium are generally high and only slightly reduced in the presence of serum, while cytotoxicity and cell membrane disruptive potential at physiological pH are low. Therefore, these novel agents are expected to be promising carriers for nonviral gene transfer. Moreover, we propose a general design principle for the construction of polycationic nanoparticles capable of delivering nucleic acids to the above-mentioned cells.
Collapse
Affiliation(s)
- Anja Schallon
- Process Biotechnology, University of Bayreuth, 95440 Bayreuth, Germany
| | | | | | | | | |
Collapse
|
132
|
Cationic core–shell liponanoparticles for ocular gene delivery. Biomaterials 2012; 33:7621-30. [DOI: 10.1016/j.biomaterials.2012.06.079] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2012] [Accepted: 06/26/2012] [Indexed: 12/12/2022]
|
133
|
The attenuation of restenosis following arterial gene transfer using carbon nanotube coated stent incorporating TAT/DNAAng1+Vegf nanoparticles. Biomaterials 2012; 33:7655-64. [DOI: 10.1016/j.biomaterials.2012.06.096] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2012] [Accepted: 06/29/2012] [Indexed: 11/20/2022]
|
134
|
Liu HF, Li W, Lu MB, Yu LJ. Pharmacokinetics and risk evaluation of DNA vaccine against Schistosoma japonicum. Parasitol Res 2012; 112:59-67. [PMID: 22990210 DOI: 10.1007/s00436-012-3104-6] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2012] [Accepted: 08/24/2012] [Indexed: 02/03/2023]
Abstract
DNA plasmid immunization is a novel approach of preventive and therapeutic vaccine. More than 100 DNA vaccines have been on preclinical or clinical phase trials, and four kinds of DNA vaccines for livestock have been approved by USDA, CFIA, and APVMA. Schistosomiasis is a worldwide parasitic disease, and vaccine immunization is supposed to be a promising approach to control the health crisis. On the basis of former preclinical studies, we further focused on the pharmacokinetics and risk evaluation of DNA vaccine in vivo. In the present study, enhanced green fluorescent protein (EGFP) report gene was fused with Schistosoma japonicum 23 kDa transmembrane protein antigen gene (Sj23) and constructed into DNA vaccine pVIVO2-Sj23.EGFP. After intramuscularly injecting 100 μg of purified DNA vaccine plasmid to immunizate BALB/c mice, we studied the tissue distribution of DNA plasmid and expressed Sj23.EGFP antigen, the persistence time of elicited antibodies, and the risk of DNA vaccine transferred into intestinal microorganisms. The results showed that DNA vaccine plasmid could be distributed into all tissues of the body after injection; however, only few organs including the injected muscle were detected DNA vaccine at postimmunization until the 100 days by PCR technology; the detection of green fluorescence protein displayed that DNA vaccine could be expressed in almost every tissue and organs; the ELISA assay indicated the immune antibody against Sj23 could persist over 70 days; and the DNA vaccine transferring intestinal flora results was negative. The results indicated that the DNA vaccine has systemic protection and long-lasting effectivity and is safe to intestinal flora.
Collapse
Affiliation(s)
- Hai-Feng Liu
- College of Life Science and Technology, Huazhong University of Science and Technology, 430074, Wuhan, China.
| | | | | | | |
Collapse
|
135
|
Even-Chen S, Cohen R, Barenholz Y. Factors affecting DNA binding and stability of association to cationic liposomes. Chem Phys Lipids 2012; 165:414-23. [PMID: 22715503 DOI: 10.1016/j.chemphyslip.2012.03.006] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Lipoplexes are complexes formed between cationic liposomes (L(+)) and polyanionic nucleic acids (P(-)). They are commonly used in vitro and in vivo as a nucleic acid delivery system. Our study aims are to investigate how DOTAP-based cationic liposomes, which vary in their helper lipid (cholesterol or DOPE) and in media of different ionic strengths affect the degree, mode of association and degree of condensation of pDNA. This was determined by ultracentrifugation and gel electrophoresis, methods based on different physical principles. In addition, the degree of pDNA condensation was also determined using the ethidium bromide (EtBr) intercalation assay. The results suggest that for cationic lipid compositions (DOTAP/DOPE and DOTAP/cholesterol), 1.5 M NaCl, but not 0.15 M NaCl, both prevent lipoplex formation and/or induce partial dissociation between lipid and DNA of preformed lipoplexes. The higher the salt concentration the greater is the similarity of DNA condensation (monitored by EtBr intercalation) between lipoplex DNA and free DNA. As determined by ultracentrifugation and agarose gel electrophoresis, 30-90% of the DNA is uncondensed. SDS below its critical micellar concentration (CMC) induced "de-condensation" of DNA without its physical release (assessed by ultracentrifugation) for both DOTAP/DOPE and DOTAP/cholesterol lipoplexes. As was assessed by agarose gel electrophoresis SDS induced release of 50-60% of DNA from the DOTAP/cholesterol lipoplex but not from the DOTAP/DOPE lipoplex. This study shows that there are conditions under which DNA is still physically associated with the cationic lipids but undergoes unwinding to become less condensed. We also proved that the helper lipid affects level and strength of the L(+) and DNA(-) electrostatic association; these interactions are weaker for DOTAP/cholesterol than for DOTAP/DOPE, despite the fact that the positive charge and surface pH of DOTAP/cholesterol and DOTAP/DOPE are similar.
Collapse
Affiliation(s)
- Simcha Even-Chen
- Laboratory of Membrane and Liposome Research, Department of Biochemistry, IMRIC, The Hebrew University, Hadassah Medical School, P.O. Box 12272, Jerusalem 91120, Israel
| | | | | |
Collapse
|
136
|
Song H, Wang G, He B, Li L, Li C, Lai Y, Xu X, Gu Z. Cationic lipid-coated PEI/DNA polyplexes with improved efficiency and reduced cytotoxicity for gene delivery into mesenchymal stem cells. Int J Nanomedicine 2012; 7:4637-48. [PMID: 22942645 PMCID: PMC3428250 DOI: 10.2147/ijn.s33923] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023] Open
Abstract
BACKGROUND Effective gene transfection without serum deprivation is a prerequisite for successful stem cell-based gene therapy. Polyethylenimine (PEI) is an efficient nonviral gene vector, but its application has been hindered by serum sensitivity and severe cytotoxicity. METHODS To solve this problem, a new family of lipopolyplexes was developed by coating PEI/DNA polyplexes with three serum-resistant cationic lipids, namely, lysinylated, histidylated, and arginylated cholesterol. The physical properties, transfection efficiency, cellular uptake, subcellular distribution, and cytotoxicity of the lipopolyplexes was investigated. RESULTS The outer coat composed of lysinylated or histidylated cholesterol remarkably improved the transfection efficiency of the polyplex with a low PEI/DNA ratio of 2 in the presence of serum. The resulting lysinylated and histidylated cholesterol lipopolyplexes were even more efficient than the best performing polyplex with a high PEI/DNA ratio of 10. Results from cellular uptake and subcellular distribution studies suggest that their higher transfection efficiency may result from accelerated DNA nuclear localization. The superiority of the lipopolyplexes over the best performing polyplex was also confirmed by delivering the therapeutic gene, hVEGF(165). Equally importantly, the lipid coating removed the necessity of introducing excess free PEI chains into the transfection solution for higher efficiency, generating lipopolyplexes with no signs of cytotoxicity. CONCLUSION Noncovalent modification of polyplexes with lysinylated and histidylated cholesterol lipids can simultaneously improve efficiency and reduce the toxicity of gene delivery under serum conditions, showing great promise for genetic modification of bone marrow stem cells.
Collapse
Affiliation(s)
- Hongmei Song
- National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, People's Republic of China
| | | | | | | | | | | | | | | |
Collapse
|
137
|
In vivo transient expression for the functional analysis of polydnaviral genes. J Invertebr Pathol 2012; 111:152-9. [PMID: 22884446 DOI: 10.1016/j.jip.2012.07.025] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2012] [Revised: 07/24/2012] [Accepted: 07/25/2012] [Indexed: 12/21/2022]
Abstract
Transient expression of a foreign gene in an organism is useful to determine its physiological function. This study introduces an efficient expression technique in the insect system using a recombinant eukaryotic expression vector. A recombinant construct expressing an enhanced green fluorescence protein (EGFP) gene under an immediately early promoter was injected into the larval hemocoel of Spodoptera exigua along with a cell transfection reagent. The expression of EGFP occurred earlier, and persisted for longer period with increasing injection dose. However, there was significant variation in expression efficiency among different cell transfection reagents. In addition, the transfection efficiency measured by RT-PCR varied among tissues with high expression of EGFP in hemocytes and fat body, but not in epidermis, gut, and nerve tissues. Two functional genes (CpBV15α and CpBV15β) derived from a polydnavirus were inserted into the eukaryotic expression vector and injected into S. exigua larvae. Expression levels in hemocytes and fat body were measured by RT-PCR and immunofluorescence assay. Both mRNAs and proteins were detected in the two tissues, in which expression signals depended on the amount of injected DNA. These immunosuppressive factors significantly inhibited hemocyte behavior, such as hemocyte-spreading, nodule formation, and phagocytosis. These results demonstrate the use of in vivo transient expression of polydnaviral genes for direct analysis of biological function in the host insect.
Collapse
|
138
|
Guo H, Hao R, Wei Y, Sun D, Sun S, Zhang Z. Optimization of electrotransfection conditions of mammalian cells with different biological features. J Membr Biol 2012; 245:789-95. [PMID: 22836669 DOI: 10.1007/s00232-012-9480-0] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2012] [Accepted: 06/30/2012] [Indexed: 11/29/2022]
Abstract
We introduced eukaryotic expression plasmid pEGFP-N1 encoding green fluorescent protein (GFP) genes into cells with different biological features through electroporation. The effects of conditions, including voltage, capacitor flow, pulse cycle, DNA dosage and buffer, on transfection efficiency were investigated based on fluorescent microscopy and posttransfection survival rate of cells by staining with trypan blue. Better electrotransfection outcomes were achieved in the following epithelial cells: Vero cells at 300 V/850 μF, PK15 cells at 300 V/500 μF, MDCK cells at 200 V/600 μF, F81 cells at 200 V/500 μF, cancer cells MB49 at 300 V/400 μF, Hela cells at 200 V/450 μF, HF-29 cells at 300 V/800 μF and B16F1 cells at 200 V/650 μF. Among fibroblast cells, better electrotransfection was achieved in BHK21 cells at 300 V/600 μF and ST cells at 200 V/750 μF. RPMI-1640 medium without antibiotics and serum demonstrated higher electrotransfection efficiency and cell survival rate than other cell culture media as electroporation buffer. Our findings further prove that electroporation transfection is an effective method for genetic transfection. Cells with different biological features require varying transfection conditions to obtain higher transfection efficiency of target genes.
Collapse
Affiliation(s)
- Huichen Guo
- State Key Laboratory of Veterinary Etiological Biology and National Foot and Mouth Disease Reference Laboratory, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Xujiaping 1, Lanzhou, 730046 Gansu, People's Republic of China.
| | | | | | | | | | | |
Collapse
|
139
|
Rosario FJ, Sadovsky Y, Jansson T. Gene targeting in primary human trophoblasts. Placenta 2012; 33:754-62. [PMID: 22831880 DOI: 10.1016/j.placenta.2012.07.003] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/07/2012] [Revised: 07/04/2012] [Accepted: 07/05/2012] [Indexed: 12/18/2022]
Abstract
Studies in primary human trophoblasts provide critical insights into placental function in normal and complicated pregnancies. Mechanistic studies in these cells require experimental tools to modulate gene expression. Lipid-based methods to transfect primary trophoblasts are fairly simple to use and allow for the efficient delivery of nucleic acids, but potential toxic effects limit these methods. Viral vectors are versatile transfection tools of native trophoblastic or foreign cDNAs, providing high transfection efficiency, low toxicity and stable DNA integration into the trophoblast genome. RNA interference (RNAi), using small interfering RNA (siRNA) or microRNA, constitutes a powerful approach to silence trophoblast genes. However, off-target effects, such as regulation of unintended complementary transcripts, inflammatory responses and saturation of the endogenous RNAi machinery, are significant concerns. Strategies to minimize off-target effects include using multiple individual siRNAs, elimination of pro-inflammatory sequences in the siRNA construct and chemical modification of a nucleotide in the guide strand or of the ribose moiety. Tools for efficient gene targeting in primary human trophoblasts are currently available, albeit not yet extensively validated. These methods are critical for exploring the function of human trophoblast genes and may provide a foundation for the future application of gene therapy that targets placental trophoblasts.
Collapse
Affiliation(s)
- F J Rosario
- Center for Pregnancy and Newborn Research, Department of Obstetrics and Gynecology, University of Texas Health Science Center San Antonio, Mail Code 7836, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA
| | | | | |
Collapse
|
140
|
Yan J, Berezhnoy NV, Korolev N, Su CJ, Nordenskiöld L. Structure and internal organization of overcharged cationic-lipid/peptide/DNA self-assembly complexes. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES 2012; 1818:1794-800. [DOI: 10.1016/j.bbamem.2012.03.022] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/23/2011] [Revised: 03/15/2012] [Accepted: 03/30/2012] [Indexed: 10/28/2022]
|
141
|
Bohinc K, Brezesinski G, May S. Modeling the influence of adsorbed DNA on the lateral pressure and tilt transition of a zwitterionic lipid monolayer. Phys Chem Chem Phys 2012; 14:10613-21. [PMID: 22751623 DOI: 10.1039/c2cp40923b] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Certain lipid monolayers at the air-water interface undergo a second-order transition from a tilted to an untilted liquid-crystalline state of their lipid hydrocarbon chains at sufficiently large lateral pressure. Recent experimental observations demonstrate that in the presence of divalent cations DNA adsorbs onto a zwitterionic lipid monolayer and decreases the tilt transition pressure. Lowering of the tilt transition pressure indicates that the DNA condenses the lipid monolayer laterally. To rationalize this finding we analyze a theoretical model that combines a phenomenological Landau approach with an extension of the Poisson-Boltzmann model to zwitterionic lipids. Based on numerical calculations of the mean-field electrostatic free energy of a zwitterionic lipid monolayer-DNA complex in the presence of divalent cations, we analyze the thermodynamic equilibrium of DNA adsorption. We find that adsorbed DNA induces a 10% reduction of the electrostatic contribution to the lateral pressure exerted by the monolayer. This result implies a small but notable decrease in the tilt transition pressure. Additional mechanisms due to ion-ion correlations and headgroup reorientations are likely to further enhance this decrease.
Collapse
Affiliation(s)
- Klemen Bohinc
- Faculty of Health Sciences, University of Ljubljana, SI-1000 Ljubljana, Slovenia.
| | | | | |
Collapse
|
142
|
Sacheli R, Delacroix L, Vandenackerveken P, Nguyen L, Malgrange B. Gene transfer in inner ear cells: a challenging race. Gene Ther 2012; 20:237-47. [PMID: 22739386 DOI: 10.1038/gt.2012.51] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Recent advances in human genomics led to the identification of numerous defective genes causing deafness, which represent novel putative therapeutic targets. Future gene-based treatment of deafness resulting from genetic or acquired sensorineural hearing loss may include strategies ranging from gene therapy to antisense delivery. For successful development of gene therapies, a minimal requirement involves the engineering of appropriate gene carrier systems. Transfer of exogenous genetic material into the mammalian inner ear using viral or non-viral vectors has been characterized over the last decade. The nature of inner ear cells targeted, as well as the transgene expression level and duration, are highly dependent on the vector type, the route of administration and the strength of the promoter driving expression. This review summarizes and discusses recent advances in inner ear gene-transfer technologies aimed at examining gene function or identifying new treatment for inner ear disorders.
Collapse
Affiliation(s)
- R Sacheli
- GIGA-Neurosciences, Developmental Neurobiology Unit, University of Liège, Liège, Belgium
| | | | | | | | | |
Collapse
|
143
|
Xiang S, Su J, Tong H, Yang F, Tong W, Yuan W, Wu F, Wang C, Jin T, Dai K, Zhang X. Biscarbamate cross-linked low molecular weight PEI for delivering IL-1 receptor antagonist gene to synoviocytes for arthritis therapy. Biomaterials 2012; 33:6520-32. [PMID: 22695070 DOI: 10.1016/j.biomaterials.2012.05.044] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2012] [Accepted: 05/20/2012] [Indexed: 01/08/2023]
Abstract
Cytoxicity is an essential concern for polyethyleneimine 25 kDa (PEI 25 kDa), a widely reported, highly effective transfection agent used in gene delivery. In our recent experiments, Small molecular weight cross-linked poly(ethylene imine) by biscarbamate linkage (PEI-Bu) (Mn: 3278, Mw: 4289) can reduce target cell apoptosis induced by polycationic transfection, and has almost the same DNA condensation capability as PEI 25 kDa. PEI-Bu showed significantly higher activity and lower cytotoxicity than PEI 25 kDa in transfecting the anti-inflammatory cytokine interleukin-1 receptor antagonist (IL-1Ra) gene to rat synoviocytes, an optimal target for arthritis treatment. The expression of IL-1Ra in synoviocytes then suppresses the expression of metalloproteases 13 (MMP13) gene, which is responsible for cartilage destruction regulated by IL-1β in arthritis. In conclusion, PEI-Bu is a promising tool for delivering IL-1Ra gene to synoviocytes for arthritis therapy.
Collapse
Affiliation(s)
- Shengnan Xiang
- The Key Laboratory of Stem Cell Biology, Shanghai Jiao Tong University School of Medicine (SJTUSM) & Shanghai Institutes for Biological Sciences (SIBS), Chinese Academy of Sciences (CAS), Shanghai, PR China
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
144
|
Heller R, Shirley S, Guo S, Donate A, Heller L. Electroporation based gene therapy--from the bench to the bedside. ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. ANNUAL INTERNATIONAL CONFERENCE 2012; 2011:736-8. [PMID: 22254415 DOI: 10.1109/iembs.2011.6090167] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
A critical aspect of gene transfer is effective delivery of the transgene to the appropriate target. Electrically mediated delivery (electroporation) of plasmid DNA has been accepted as a viable approach to achieve effective delivery. One promising area is delivering plasmid DNA to skin. Gene transfer to the skin with electroporation is currently being evaluated for its potential for inducing angiogenesis for wound healing and for delivering DNA vaccines to the skin. Experiments utilizing a plasmid encoding for vascular endothelial growth factor has demonstrated how wound healing could be accelerated. In another study, delivery of a plasmid encoding Hepatitis B surface antigen have demonstrated that high antibody titers can be induced after two applications (prime/boost). Our laboratory has also examined the use of electroporation to delivery plasmid DNA encoding various cytokines as a potential therapy for melanoma. The plasmid is injected directly into the tumor followed by the administration of electroporation. Extensive preclinical work provided the rationale for a Phase I proof of concept first in human trial in patients with accessible cutaneous melanoma metastases. Biopsies of treated lesions showed significant necrosis of melanoma cells within the tumor as well as IL-12 expression. Lymphocytic infiltrate was observed in biopsies from patients in several cohorts. Clinical evidence of responses in untreated lesions suggested there was a systemic response following therapy was observed. Since this trial several other clinical studies utilizing electroporation to deliver plasmid DNA have been initiated. It is clear that this delivery approach has tremendous potential to facilitate the translation of gene transfer protocols from the bench to the bedside.
Collapse
Affiliation(s)
- Richard Heller
- Frank Reidy Research Center for Bioelectrics, Old Dominion University, Norfolk, VA 23508, USA.
| | | | | | | | | |
Collapse
|
145
|
Somiya M, Yoshimoto N, Iijima M, Niimi T, Dewa T, Jung J, Kuroda S. Targeting of polyplex to human hepatic cells by bio-nanocapsules, hepatitis B virus surface antigen L protein particles. Bioorg Med Chem 2012; 20:3873-9. [DOI: 10.1016/j.bmc.2012.04.031] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2012] [Revised: 04/15/2012] [Accepted: 04/16/2012] [Indexed: 11/16/2022]
|
146
|
Gwak SJ, Jung JK, An SS, Kim HJ, Oh JS, Pennant WA, Lee HY, Kong MH, Kim KN, Yoon DH, Ha Y. Chitosan/TPP-hyaluronic acid nanoparticles: a new vehicle for gene delivery to the spinal cord. JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION 2012; 23:1437-50. [PMID: 21781382 DOI: 10.1163/092050611x584090] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Gene delivery offers therapeutic promise for the treatment of neurological diseases and spinal cord injury. Several studies have offered viral vectors as vehicles to deliver therapeutic agents, yet their toxicity and immunogenicity, along with the cost of their large-scale formulation, limits their clinical use. As such, non-viral vectors are attractive in that they offer improved safety profiles compared to viruses. Poly(ethylene imine) (PEI) is one of the most extensively studied non-viral vectors, but its clinical value is limited y its cytotoxicity. Recently, chitosan/DNA complex nanoparticles have een considered as a vector for gene delivery. Here, we demonstrate that DNA nanoparticles made of hyaluronic acid (HA) and chitosan have low cytotoxicity and induce high transgene expression in neural stem cells and organotypic spinal cord slice tissue. Chitosan-TPP/HA nanoparticles were significantly less cytotoxic than PEI at various concentrations. Additionally, chitosan-TPP/HA nanoparticles with pDNA induced higher transgene expression in vitro for a longer duration than PEI in neural stem cells. These results suggest chitosan-TPP/HA nanoparticles may have the potential to serve as an option for gene delivery to the spinal cord.
Collapse
Affiliation(s)
- So-Jung Gwak
- a Spine & Spinal Cord Institute, Department of Neurosurgery, Yonsei University College of Medicine , 120-752, 134 Shinchon-dong , Seodaemoon-gu , Seoul , South Korea
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
147
|
Abstract
Many devastating human diseases are caused by mutations in a single gene that prevent a somatic cell from carrying out its essential functions, or by genetic changes acquired as a result of infectious disease or in the course of cell transformation. Targeted gene therapies have emerged as potential strategies for treatment of such diseases. These therapies depend upon rare-cutting endonucleases to cleave at specific sites in or near disease genes. Targeted gene correction provides a template for homology-directed repair, enabling the cell's own repair pathways to erase the mutation and replace it with the correct sequence. Targeted gene disruption ablates the disease gene, disabling its function. Gene targeting can also promote other kinds of genome engineering, including mutation, insertion, or gene deletion. Targeted gene therapies present significant advantages compared to approaches to gene therapy that depend upon delivery of stably expressing transgenes. Recent progress has been fueled by advances in nuclease discovery and design, and by new strategies that maximize efficiency of targeting and minimize off-target damage. Future progress will build on deeper mechanistic understanding of critical factors and pathways.
Collapse
Affiliation(s)
- Olivier Humbert
- Departments of Immunology and Biochemistry, University of Washington School of Medicine, Seattle, WA 98195, USA
| | | | | |
Collapse
|
148
|
Tang J, Chen JY, Liu J, Luo M, Wang YJ, Wei XW, Gao X, Wang BL, Liu YB, Yi T, Tong AP, Song XR, Xie YM, Zhao Y, Xiang M, Huang Y, Zheng Y. Calcium phosphate embedded PLGA nanoparticles: a promising gene delivery vector with high gene loading and transfection efficiency. Int J Pharm 2012; 431:210-21. [PMID: 22561795 DOI: 10.1016/j.ijpharm.2012.04.046] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2011] [Revised: 03/27/2012] [Accepted: 04/17/2012] [Indexed: 10/28/2022]
Abstract
In the purpose of increasing incorporation efficiency and improving the release kinetics of plasmid DNA (pDNA) from poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles, a facile method for the fabrication of calcium phosphate (CaPi) embedded PLGA nanoparticles (CaPi-pDNA-PLGA-NPs) was developed. The effect of several preparation factors on the particle size, incorporation efficiency, pDNA release and transfection efficiency in vitro was studied by Single Factor Screening Method. These preparation factors included the molecular weight (MW), hydrolysis degree (HD) of polyvinyl alcohol (PVA), sonication power and time, composition of organic phase, initial concentration of calcium phosphate and calcium (Ca) to phosphate ion (P) ratio (Ca/P ratio), etc. The CaPi-pDNA-PLGA-NPs made according to the optimal formulation were spherical in shape observed by transmission electron microscopy (TEM) with a mean particle size of 207±5 nm and an entrapment efficiency of 95.7±0.8%. Differential scanning calorimetry (DSC) suggested that there existed interaction between the DNA-calcium-phosphate (CaPi-pDNA) complexes and the polymeric matrices of PLGA. X-ray diffractometry (XRD) further proved the conclusion and indicated that the CaPi-pDNA was in weak crystallization form inside the nanoparticles. The Brunauer-Emmett-Teller (BET) surface area measurement demonstrated that the CaPi-pDNA-PLGA-NPs are mesoporous with specific surface area of 57.5m(2)/g and an average pore size of 96.5 Å. The transfection efficiency of the CaPi-pDNA-PLGA-NPs on human embryonic kidney 293 (HEK 293) cells in vitro was 22.4±1.2%, which was much higher than those of both the pDNA loaded PLGA nanoparticles (pDNA-PLGA-NPs) and the CaPi-pDNA embedded PLGA microparticles (CaPi-pDNA-PLGA-MPs). The CaPi-pDNA-PLGA-NPs are promising vectors for gene delivery.
Collapse
Affiliation(s)
- Jie Tang
- College of Pharmacy, State Key Laboratory of Biotherapy, Sichuan University, No. 17, Section 3, Renmin Nan Road, Chengdu 610041, PR China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
149
|
Zhou Y, Wang H, Wang C, Li Y, Lu W, Chen S, Luo J, Jiang Y, Chen J. Receptor-Mediated, Tumor-Targeted Gene Delivery Using Folate-Terminated Polyrotaxanes. Mol Pharm 2012; 9:1067-76. [PMID: 22482910 DOI: 10.1021/mp200315c] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Yi Zhou
- Department of Pharmaceutical
Science, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
| | - He Wang
- Institute for Cancer Research, Southern Medical University, Guangzhou 510515, China
| | - Chengxi Wang
- Department of Pharmaceutical
Science, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
| | - Yueshan Li
- Department of Pharmaceutical Science, Guangzhou Medical University, Guangzhou 510182, China
| | - Wenfeng Lu
- Department of Pharmaceutical
Science, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
| | - Shuifang Chen
- Department of Pharmaceutical
Science, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
| | - Jiandong Luo
- Department of Pharmaceutical Science, Guangzhou Medical University, Guangzhou 510182, China
| | - Yongnan Jiang
- Department of Pharmaceutical
Science, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
| | - Jianhai Chen
- Department of Pharmaceutical
Science, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
| |
Collapse
|
150
|
Lee D, Kim D, Mok H, Jeong JH, Choi D, Kim SH. Bioreducible Crosslinked Polyelectrolyte Complexes for MMP-2 siRNA Delivery into Human Vascular Smooth Muscle Cells. Pharm Res 2012; 29:2213-24. [DOI: 10.1007/s11095-012-0750-4] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2011] [Accepted: 03/27/2012] [Indexed: 11/25/2022]
|